Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-086655
Filing Date
2024-10-09
Accepted
2024-10-09 17:16:18
Documents
13
Period of Report
2024-09-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0217249-8ka1_onconetix.htm   iXBRL 8-K/A 56984
  Complete submission text file 0001213900-24-086655.txt   240334

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE onco-20240918.xsd EX-101.SCH 3042
3 XBRL LABEL FILE onco-20240918_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE onco-20240918_pre.xml EX-101.PRE 22377
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0217249-8ka1_onconetix_htm.xml XML 4294
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41294 | Film No.: 241363331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)